NSABP


Also found in: Acronyms.

NSABP

National Surgical Adjuvant Breast Project Oncology A series of ongoing multicenter clinical trials evaluating the effects of various therapies, including RT, surgery and chemotherapy–eg, tamoxifen and 5-FU, in treating advanced breast or colorectal CAs
References in periodicals archive ?
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically nodenegative patients with breast cancer: overall survival findings from the NSABP B32 randomised phase 3 trial.
Data from NSABP 27 reveals a pCR of 26% with addition of docetaxel sequentially to doxorubicin in preoperative setting and also better PR and CR in both ER +ve and -ve patients.
Median follow-up, Negative Trial n years margins, % NSABP B-17 [Wapniretal.
The United Kingdom, Australia, New Zealand (UK/ANZ) trial showed a significantly lower risk of ipsilateral non-invasive and invasive recurrences compared with the NSABP and EORTC trials.
Initial safety report of NSABP C-08, a randomized phase III study of modified 5-fluorouracil (5-FU)/leucovorin (LCV) and oxaliplatin (OX) (mFOLFOX6) with or without bevacizumab (bev) in the adjuvant treatment of patients with stage II/III colon cancer.
It really doesn't matter if we give chemotherapy preoperatively or postoperatively in terms of disease-free survival," said NSABP Chairman Norman Wolmark, MD, at a recent two-day conference on neoadjuvant therapy for breast cancer held at the National Institutes of Health (NIH) in Bethesda, Md.
Uno de los primeros ensayos con quimioterapia adyuvante, que demostro una mejoria de la supervivencia, fue realizado por el NSABP, ECOC y Central Oncology Group (6).
The B-06 lumpectomy controversy is one such regulatory controversy, involving, among other agencies, the Office of Research Integrity (ORI), which oversees federally sponsored health research, the National Cancer Institute (NCI), which funded the NSABP research, NEJM, which published the original research, and the University of Pittsburgh, which administered NSABP grant monies.
Eli Lilly and Company has also given NSABP a $36 million grant to defray recruitment costs at the participating centers and to help local investigators conduct the study.
In an earlier talk about the NSABP (National Surgical Adjuvant Breast & Bowel Project) P1 prevention trial, Donald Wickerham, M.
Investigations of irregularities had been instituted by NSABP and the Office of Research Integrity (ORI) of the National Institutes of Health (NIH) of the United States as early as 1991.